These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17701606)

  • 21. [The pathologist's role in the neoadjuvant strategy of renal-cell carcinoma].
    Leroy X; Edeline J; Rioux-Leclercq N
    Ann Pathol; 2011 Dec; 31(6):466-71. PubMed ID: 22172119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexistence of chronic neutrophilic leukemia with light chain myeloma.
    Cehreli C; Undar B; Akkoc N; Onvural B; Altungoz O
    Acta Haematol; 1994; 91(1):32-4. PubMed ID: 8171934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel drugs for the treatment of multiple myeloma.
    Bladé J; Cibeira MT; Rosiñol L
    Haematologica; 2010 May; 95(5):702-4. PubMed ID: 20442442
    [No Abstract]   [Full Text] [Related]  

  • 24. Induction treatment of light chain deposition disease with bortezomib: rapid hematological response with persistence of renal involvement.
    Minarik J; Scudla V; Tichy T; Pika T; Bacovsky J; Lochman P; Zadrazil J
    Leuk Lymphoma; 2012 Feb; 53(2):330-1. PubMed ID: 21883030
    [No Abstract]   [Full Text] [Related]  

  • 25. Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma.
    Grünwald V; McKay RR; Krajewski KM; Kalanovic D; Lin X; Perkins JJ; Simantov R; Choueiri TK
    Eur Urol; 2015 May; 67(5):952-8. PubMed ID: 25577718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The successful surgical treatment of hypernephroid cancer in 2 patients with multiple myeloma].
    Andreeva NE; Sinitsina TV; Kolesnikova AS
    Ter Arkh; 1990; 62(9):127-30. PubMed ID: 2281396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A coincidence of renal cell carcinoma and hematological malignancies.
    Sargın G; Yavasoglu I; Doger FK; Kadikoylu G; Bolaman Z
    Med Oncol; 2012 Dec; 29(5):3335-8. PubMed ID: 22843308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilateral renal cell carcinoma.
    Colt HG; Wholey MH
    Am Fam Physician; 1988 May; 37(5):121-5. PubMed ID: 3284299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of bortezomib in systemic extramedullary localizations of multiple myeloma.
    Federico V; Breccia M; Petrucci MT; Loglisci G; Mansueto G; Mercanti C; Levi A; Cartoni C; Musto P; Alimena G
    Clin Adv Hematol Oncol; 2012 Apr; 10(4):266-8. PubMed ID: 22706491
    [No Abstract]   [Full Text] [Related]  

  • 30. Intermittent treatment with sunitinib may achieve complete response in metastatic renal cell carcinoma.
    Aksu G; Ensaroglu F; Dolasik I; Temiz S; Halis H; Sener SY; Kaya A; Uygun K
    J BUON; 2010; 15(4):798-9. PubMed ID: 21229650
    [No Abstract]   [Full Text] [Related]  

  • 31. [Renal-cell carcinoma and multiple mieloma: synchronic association with posible immunologic pathogenesis].
    Cuadra-Urteaga JL; Font Pous A; Pardo-Aranda N; Rocafiguera AO
    Med Clin (Barc); 2012 Mar; 138(5):224-5. PubMed ID: 21719048
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical hypothyroidism in a renal cell carcinoma patient treated with sorafenib.
    Block MS; Kohli M
    Clin Adv Hematol Oncol; 2011 Apr; 9(4):335-8. PubMed ID: 21558995
    [No Abstract]   [Full Text] [Related]  

  • 33. Second malignancies associated with chemotherapeutic agents.
    Kyle RA
    Semin Oncol; 1982 Mar; 9(1):131-42. PubMed ID: 6803361
    [No Abstract]   [Full Text] [Related]  

  • 34. Extramedullary manifestations of multiple myeloma in the thyroid gland and in the lungs: excellent response to therapy.
    Weisser F; Reuter C; Taverna C
    Ann Hematol; 2010 Nov; 89(11):1183-4. PubMed ID: 20383503
    [No Abstract]   [Full Text] [Related]  

  • 35. Synchronous presentation of breast carcinoma with plasmacytoid cytomorphology and multiple myeloma.
    Khalbuss WE; Fischer G; Ahmad M; Villas B
    Breast J; 2006; 12(2):165-7. PubMed ID: 16509843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Synchronous chromophobe renal carcinoma and centrocytic lymphoma].
    Márquez Moreno AJ; Mañas Uxó J; Amores Ramírez F; Aguilar Cuevas R; Ortega Jiménez MV; Leiva Vera C; Pérez Rodríguez D
    Arch Esp Urol; 2003 May; 56(4):415-7. PubMed ID: 12830613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypercalcemia, chronic lymphocytic leukemia and multiple myeloma: uncommon association.
    Schoevaerdts D; Mineur P; Hennaux V; Sibille C
    Acta Clin Belg; 1999 Aug; 54(4):217-9. PubMed ID: 10544513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloma-like lesions of the kidney. Occurrence in a case of acinic cell adenocarcinoma of the pancreas.
    Min K; Cain GD; Györkey P; Györkey F
    Arch Intern Med; 1976 Nov; 136(11):1299-302. PubMed ID: 984991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of multiple myeloma.
    Alexanian R; Dimopoulos MA
    Semin Hematol; 1995 Jan; 32(1):20-30. PubMed ID: 7878475
    [No Abstract]   [Full Text] [Related]  

  • 40. A case of renal cell carcinoma metastatic to the nose and tongue.
    Lang EE; Patil N; Walsh RM; Leader M; Walsh MA
    Ear Nose Throat J; 2003 May; 82(5):382-3. PubMed ID: 12789766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.